Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China flag China · Delayed Price · Currency is CNY
58.56
+0.23 (0.39%)
Apr 29, 2026, 3:00 PM CST

SHA:688621 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
372.45462.17565.56690.93608.93490.25
Short-Term Investments
--20---
Trading Asset Securities
4775303013.11157.6
Cash & Short-Term Investments
419.45537.17615.56720.93622.04647.85
Cash Growth
-37.45%-12.74%-14.62%15.90%-3.98%492.70%
Accounts Receivable
1,034935.3774.96555.83362.73239.2
Other Receivables
7.496.6510.1611.2116.1712
Receivables
1,041941.95785.12567.04378.9251.21
Inventory
14.6714.0315.0514.4112.547.84
Prepaid Expenses
-----1.9
Other Current Assets
245.37247.4798.7654.7626.4832.99
Total Current Assets
1,7211,7411,5141,3571,040941.79
Property, Plant & Equipment
167.69177.91211.61220.26197.02161.05
Long-Term Investments
199.51159.41115.69100.7594.7540
Goodwill
20.5120.5126.0626.0626.0626.06
Other Intangible Assets
4.054.735.415.394.23.32
Long-Term Deferred Tax Assets
111.47102.2764.0438.9316.695.03
Long-Term Deferred Charges
27.6130.6448.2864.1976.2533.41
Other Long-Term Assets
48.5548.711.7350.318.7831.99
Total Assets
2,3002,2851,9871,8631,4641,243
Accounts Payable
60.9252.747.317.8322.1312.52
Accrued Expenses
22.1830.7477.2488.7237.2927.33
Short-Term Debt
508.93499.13309.39383.93201.17138.01
Current Portion of Long-Term Debt
34.6236.8319.3---
Current Portion of Leases
--24.7822.122.5418.98
Current Income Taxes Payable
40.6539.476.624.9216.9311.42
Current Unearned Revenue
284.87299.15321.43220.83205.85199.85
Other Current Liabilities
10.2910.5812.5112.8812.279.72
Total Current Liabilities
962.47968.65778.56761.21518.19417.83
Long-Term Debt
38.44867.2---
Long-Term Leases
26.729.7535.1240.6233.8449.72
Long-Term Unearned Revenue
3.573.572.523.592.835.46
Long-Term Deferred Tax Liabilities
0.020.051.250.350.24-
Other Long-Term Liabilities
1.281.28----
Total Liabilities
1,0321,051884.65805.76555.1473.01
Common Stock
1121121121128080
Additional Paid-In Capital
422.36406.54375.86474.17499.85499.85
Retained Earnings
819.46798.83612.78453.85317.09182.1
Treasury Stock
-100-100----
Total Common Equity
1,2541,2171,1011,040896.93761.95
Minority Interest
13.9216.122.0117.2511.677.69
Shareholders' Equity
1,2681,2331,1031,057908.6769.64
Total Liabilities & Equity
2,3002,2851,9871,8631,4641,243
Total Debt
608.65613.71455.79446.65257.55206.71
Net Cash (Debt)
-189.2-76.55159.77274.28364.48441.14
Net Cash Growth
---41.75%-24.75%-17.38%414.12%
Net Cash Per Share
-1.71-0.701.422.453.264.50
Filing Date Shares Outstanding
114.62109.66112112112112
Total Common Shares Outstanding
114.62109.66112112112112
Working Capital
758.31771.97735.93595.93521.77523.96
Book Value Per Share
10.9411.109.839.298.016.80
Tangible Book Value
1,2291,1921,0691,009866.68732.57
Tangible Book Value Per Share
10.7210.879.559.017.746.54
Machinery
--256.34232.62195.9124.14
Construction In Progress
-----3.4
Order Backlog
--3,273---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.